Federal Register / Vol. 65, No. 96 / Wednesday, May 17, 2000 / Notices 31327

(1) The proposed plan for the

inclusion of both sexes and racial and

ethnic minority populations for

appropriate representation.

(2) The proposed justification when

representation is limited or absent.

5. Community Involvement and

Dissemination of Results (20 percent)

a. A clear identification and

description of the community(ies) to be

involved in this project.

b. Adequacy of plan for recruitment

and outreach for study participants

including the process of establishing

partnerships with community(ies) and

recognition of the mutual benefits.

c. A statement as to whether the plans

for recruitment and outreach for study

participants include the process of

establishing partnerships with

communities and recognition of mutual

benefits.

d. Adequacy of plans to address

community concerns and create lines of

communication, including letters of

support.

e. Adequacy of methods to

disseminate the study results to

community residents, state and local

public health officials, tribal

governments, Indian Health Service,

and to other concerned individuals and

organizations.

6. Facilities and Resources (10 percent)

The adequacy of the applicant’s

facilities, equipment, and other

resources available for performance of

this project.

7. Human Subjects (Not scored)

Does the application adequately

address the requirements of 45 CFR 46

for the protection of human subjects?

8. Budget Justification (Not scored)

The budget will be evaluated to the

extent that it is reasonable, clearly

justified, and consistent with the

intended use of funds.

H. Other Requirements

Technical Reporting Requirements

Provide CDC with the original and

two copies of:

1. Semi-annual progress report.

2. Financial Status Report (FSR) no

more than 90 days after the end of the

budget period.

3. Final financial status report and

performance report, no more than 90

days after the end of the project.

Send all reports to the Grants

Management Specialist identified in the

‘‘Where to Obtain Additional

Information’’ section of this

announcement.

The following additional

requirements are applicable to this

program. For a complete description of

each, see Attachment 1 in the

application kit.

AR–1 Human Subjects Requirements

AR–2 Requirements of Inclusion of

Women and Racial and Ethnic

Minorities in Research

AR–7 Executive Order 12372 Review

AR–10 Smoke-Free Workplace

Requirements AR–11 Healthy People 2010

AR–12 Lobbying Restrictions

AR–17 Peer Review and Technical

Reviews of Final Reports of Health

Studies—ATSDR

AR–18 Cost Recovery—ATSDR

AR–19 Third Party Agreements—

ATSDR

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized in

Sections 104(i)(1)(E) and (15) of the

Comprehensive Environmental

Response, Compensation, and Liability

Act (CERCLA) as amended by the

Superfund Amendments and

Reauthorization Act (SARA) [42 U.S.C.

9604 (i)(l)(E) and (15)]. The Catalog of

Federal Domestic Assistance number is

93.161.

J. Where To Obtain Additional

Information

Please refer to Program

Announcement 00114 when you request

information.

This and other ATSDR

announcements can be found on the

CDC home page Internet address:

http://www.cdc.gov. Click on

‘‘Funding’’ then ‘‘Grants and

Cooperative Agreements.’’ To receive additional written

information and to request an

application kit, call 1–888–GRANTS4

(1–888 472–6874). You will be asked to

leave your name and address and will

be instructed to identify the

Announcement number of interest.

If you have questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained from: Nelda

Y. Godfrey, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 2920 Brandywine Road, Suite

3000, Atlanta, Georgia 30341–4146,

Telephone (770) 488–2722, E-mail

address: nag9@cdc.gov. For program assistance, contact:

Curtis Noonan, Epidemiologist, Health

Investigations Branch, Division of

Health Studies, Agency for Toxic

Substances and Disease Registry, 1600

Clifton Road, NE., Mail Stop E–31,

Atlanta, Georgia 30333, Telephone:

(404) 639–5150, E-mail address:

cen9@cdc.gov.

Dated: May 11, 2000.

Georgi Jones,

Director, Office of Policy and External Affairs,

Agency for Toxic Substances and Disease

Registry.

[FR Doc. 00–12347 Filed 5–16–00; 8:45 am]

BILLING CODE 4163–70–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[60Day–00–37]

Proposed Data Collections Submitted

for Public Comment and

Recommendations

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Centers for Disease Control and

Prevention is providing opportunity for

public comment on proposed data

collection projects. To request more

information on the proposed projects or

to obtain a copy of the data collection

plans and instruments, call the CDC

Reports Clearance Officer on (404) 639–

7090.

Comments are invited on: (a) Whether

the proposed collection of information

is necessary for the proper performance

of the functions of the agency, including

whether the information shall have

practical utility; (b) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (c)

ways to enhance the quality, utility, and

clarity of the information to be

collected; and (d) ways to minimize the

burden of the collection of information

on respondents, including through the

use of automated collection techniques

for other forms of information

technology. Send comments to Anne E.

O’Connor, CDC Assistant Reports

Clearance Officer, 1600 Clifton Road,

MS–D24, Atlanta, GA 30333. Written

comments should be received within 60

days of this notice.

Proposed Projects

Racial and Ethnic Approaches to

Community Health—National Center for

Chronic Disease Prevention and Health

Promotion (NCCDPHP). The REACH

2010 Demonstration Program is a part of

the Department of Health and Human

Services’ response to the President’s

Race Initiative and to the Healthy

People 2010 goal to eliminate disparities

in the health status of racial and ethnic

minorities. The purpose of REACH 2010

31328 Federal Register / Vol. 65, No. 96 / Wednesday, May 17, 2000 / Notices

is to demonstrate that adequately

funded community-based programs

which are designed and led by the

communities they serve can reduce

health disparities in infant mortality,

deficits in breast and cervical cancer

screening and management,

cardiovascular diseases, diabetes, HIV/

AIDS, and deficits in childhood and

adult immunizations. The communities

served by REACH 2010 include: African

American, American Indian, Hispanic

American, Asian American, and Pacific

Islander. Thirty-two communities were

funded in Phase I to construct

Community Action Plans (CAP). In

Phase II, 17 of those communities will

receive continued funding to implement

their CAP.

As part of the President’s Race

Initiative, it is imperative that REACH

2010 demonstrate success in reducing

health disparities among racial and

ethnic minority populations. Toward

that end, it is of critical importance that

CDC collect uniform survey data from

each of the 17 communities funded for

the Phase II REACH 2010 Demonstration

Program. The same survey will be

conducted in each community; it will

contain questions that are standard

public health performance measures for

each health priority area. Surveys will

be administered by either telephone or

household interview. These surveys will

be administered annually for four years

using a different sample from each

community.

The total annualized burden hours for

this project is 4080 hours.

Respondents Number of

respondents

Number of

responses/

respondent

Average

burden of

response

(in hours)

Total burden

(in hours)

Adults ages 18 and older who live in communities participating in the

REACH 2010 Program ................................................................................. 16,320 1 15/60 4080

Total ...................................................................................................... ........................ ........................ ........................ 4080

Dated: May 11, 2000.

Nancy Cheal,

Acting Associate Director for Policy,

Planning, and Evaluation, Centers for Disease

Control and Prevention.

[FR Doc. 00–12344 Filed 5–16–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30DAY–32–00]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Officer at (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

Proposed Project

1. Emergency Epidemic

Investigations—(0920–0008)—

Extension—Epidemiology Program

Office (EPO)—One of the objectives of

CDC’s epidemic services is to provide

for the prevention and control of

epidemics and protect the population

from public health crises such as man

made or natural biological disasters and

chemical emergencies. This is carried

out, in part, by training investigators,

maintaining laboratory capabilities for

identifying potential problems,

collecting and analyzing data, and

recommending appropriate actions to

protect the public’s health. When state,

local, or foreign health authorities

request help in controlling an epidemic

or solving other health problems, CDC

dispatches skilled epidemiologists from

the Epidemic Intelligence Service (EIS)

to investigate and resolve the problem.

Resolving public health problems

rapidly ensures costs effective health

care and enhances health promotion

and disease prevention. Annually, the

EIS Program coordinates 400 Epidemic

Assistance Investigations (Epi-Aids) and

state-based field investigations.

Epidemics are prevented and controlled

by mobilizing and deploying CDC staff,

primarily EIS officers to respond rapidly

to disease outbreaks and disaster

situations. At the request of public

health officials—at the state, national, or

international level—CDC provides

assistance by participating in

epidemiologic field investigations. The

purpose of the Emergency Epidemic

Investigation surveillance is to collect

data on the conditions surrounding and

preceding the onset of a problem. The

data must be collected in a timely

fashion so that information can be used

to develop prevention and control

techniques, to interrupt disease

transmission and to help identify the

cause of an outbreak. Since the events

necessitating the collections of

information are of an emergency nature,

most data collection is done by direct

interview or written questionnaire and

are one-time efforts related to a specific

outbreak or circumstance. If during the

emergency investigation, the need for

further study is recognized, a project is

designed and separate OMB clearance is

required. Interviews are conducted to be

as unobtrusive as possible and only the

minimal information necessary is

collected. The Emergency Epidemic

Investigations is the principal source of

data on outbreaks of infectious and

noninfectious diseases, injuries,

nutrition, environmental health and

occupational problems.

Each investigation does contribute to

the general knowledge about a

particular type of problem or

emergency, so that data collections are

designed taking into account similar

situations in the past. Some

questionnaires have been standardized,

such as investigations of outbreaks

aboard aircraft or cruise vessels.

The Emergency Epidemic

Investigations provides a range of data

on the characteristics of outbreaks and

those affected by them. Data collected

include demographic characteristics,

exposure to the causative agent(s),

transmission patterns and severity of the

outbreak on the affected population.

These data, together with trend data,

may be used to monitor the effects of

change in the health care system,

planning of health services, improving

the availability of medical services and

assessing the health status of the

population.

Users of the Emergency Epidemic

Investigations data include, but are not

limited to EIS Officers in investigating

the patterns of disease or injury,

investigating the level of risky